These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 17983513)

  • 1. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Wan XR; Sun ZJ; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
    Xiang Y; Sun Z; Wan X; Yang X
    J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score > or = 7.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2010; 55(5-6):199-207. PubMed ID: 20626175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with 5-fluorouracil, methotrexate and etoposide for patients with high-risk gestational trophoblastic tumors: a report based on our 11-year clinical experiences.
    Wang S; An R; Han X; Zhu K; Xue Y
    Gynecol Oncol; 2006 Dec; 103(3):1105-8. PubMed ID: 16870237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
    Soper JT; Evans AC; Rodriguez G; Berchuck A; Clarke-Pearson DL; Hammond CB
    Gynecol Oncol; 1995 Mar; 56(3):421-4. PubMed ID: 7705678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet.
    Osborne R; Covens A; Mirchandani D; Gerulath A
    J Reprod Med; 2004 Aug; 49(8):655-61. PubMed ID: 15457856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent gestational trophoblastic tumor: management and risk factors for recurrence.
    Yang J; Xiang Y; Wan X; Yang X
    Gynecol Oncol; 2006 Nov; 103(2):587-90. PubMed ID: 16750258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia.
    Ngan HY; Tam KF; Lam KW; Chan KK
    Obstet Gynecol; 2006 May; 107(5):1012-7. PubMed ID: 16648404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methotrexate combined chemotherapy for chemorefractory gestational trophoblastic tumour].
    Xiang Y; Yang X; Han S
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):97-100. PubMed ID: 11263207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment.
    Yang J; Xiang Y; Wan X; Yang X
    Gynecol Oncol; 2006 Nov; 103(2):479-82. PubMed ID: 16631244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.